Senior operating executive and investor focused on growth-stage technology and consumer businesses. Combines operating experience in product and go-to-market leadership with direct investing and board roles across software and e-commerce portfolios. David Skalicky is known for hands-on scaling of commercial teams, transaction experience in M&A and capital raises, and supporting founder-led management on strategy, metrics, and operational execution.
Senior operating executive and investor focused on growth-stage technology and consumer businesses. Combines operating experience in product and go-to-market leadership with direct investing and board roles across software and e-commerce portfolios. David Skalicky is known for hands-on scaling of commercial teams, transaction experience in M&A and capital raises, and supporting founder-led management on strategy, metrics, and operational execution.
Focuses on growth-stage technology and consumer opportunities, deploying capital to companies where product-market fit exists and commercial scaling is the primary value driver. Prefers concentrated, board-level positions enabling hands-on go-to-market and product leadership, KPI-driven operational playbooks, and follow-on funding to de-risk execution. Investment horizon is multi-year, emphasizing revenue fundamentals, unit economics, and repeatable sales motions. Risk discipline centers on staged capital, clear milestone gating, and founder alignment.
Focuses on growth-stage technology and consumer opportunities, deploying capital to companies where product-market fit exists and commercial scaling is the primary value driver. Prefers concentrated, board-level positions enabling hands-on go-to-market and product leadership, KPI-driven operational playbooks, and follow-on funding to de-risk execution. Investment horizon is multi-year, emphasizing revenue fundamentals, unit economics, and repeatable sales motions. Risk discipline centers on staged capital, clear milestone gating, and founder alignment.
| Trades 1017 | Longs Won 721/1017 70% | Profit Factor 5.15 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $421,813.47 |
| Average Win $271,880.88 | Best Trade (Aug 10) $5.63M | Sharpe Ratio -16.59 |
| Average Loss -$128,534.16 | Worst Trade (Dec 31) -$1.4M | Z-Score 17.47 (100%) |
| Commissions $0 | Avg. Trade Length 1y 4m 2w 5d | Expectancy $155,339.23 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% |
| Consecutive Losing Trades | 5,848 | 5,263 | 4,678 | 4,094 | 3,509 | 2,924 | 2,339 | 1,754 | 1,170 | 585 |
| Symbol | Quantity | Cost | Value | Comm. | Profit ($) | Gain (%) | Change |
|---|---|---|---|---|---|---|---|
AAPL Apple Inc. | 68,052 | $14.72M | $21.16M | - | $6.44M | 43.74% | +0.524% |
AGG iShares Core U.S. Aggregate Bond ETF | 4,486 | $434,693 | $437,721.45 | - | $3,028.45 | 0.7% | -0.087% |
AMT American Tower Corporation | 14,400 | $2.81M | $2.42M | - | -$387,995.13 | -13.82% | -4.097% |
AMZN Amazon.com Inc | 44,816 | $9.09M | $12.43M | - | $3.34M | 36.72% | 0.0 |
APH Amphenol Corporation | 64,056 | $5.65M | $5.49M | - | -$159,819.72 | -2.83% | 0.0 |
APTV Aptiv PLC | 60,000 | $3.76M | $2.79M | - | -$977,320 | -25.96% | -2.661% |
ARES Ares Management Corporation | 10,500 | $1.15M | $1.47M | - | $322,035 | 28.11% | -2.197% |
AVGO Broadcom Inc. | 54,689 | $10.6M | $22.87M | - | $12.27M | 115.72% | 0.0 |
B BARRICK MINING CORP Common Stock (ABR0) | 50,700 | $1.06M | $2.08M | - | $1.03M | 97.19% | +7.446% |
BA Boeing Company | 25,500 | $4.82M | $6.05M | - | $1.22M | 25.35% | 0.0 |
BABA Alibaba Group Holding Limited SP ADR | 34,000 | $3.26M | $4.37M | - | $1.11M | 33.9% | -0.364% |
BALL Ball Corp. | 67,000 | $3.95M | $4.26M | - | $307,428 | 7.78% | -0.267% |
BIIB Biogen Inc. | 20,000 | $3.63M | $4.13M | - | $505,184.98 | 13.93% | -0.873% |
BKNG Booking Holdings Inc. | 35,125 | $6.32M | $6.82M | - | $505,041.4 | 7.99% | 0.0 |
BLK BlackRock, Inc. | 4,100 | $3.94M | $4.64M | - | $694,695.16 | 17.62% | 0.0 |
BMY Bristol-Myers Squibb Company | 130,000 | $6.44M | $8.27M | - | $1.83M | 28.42% | -3.43% |
BRK-B Berkshire Hathaway Inc. | 13,200 | $5.93M | $6.83M | - | $901,527 | 15.21% | 0.0 |
BX Blackstone Inc. | 11,700 | $1.35M | $1.61M | - | $259,857 | 19.31% | 0.0 |
C Citigroup Inc. | 67,000 | $4.17M | $9.22M | - | $5.05M | 121.24% | +0.563% |
CB Chubb Limited | 32,100 | $9.12M | $11.2M | - | $2.08M | 22.8% | +0.155% |